Senti Biosciences Inc (SNTI)
0.3972
+0.02
(+4.53%)
USD |
NASDAQ |
May 17, 16:00
0.38
-0.02
(-4.33%)
After-Hours: 20:00
Senti Biosciences Total Assets (Quarterly): 102.18M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 102.18M |
| December 31, 2023 | 119.48M |
| September 30, 2023 | 131.77M |
| June 30, 2023 | 143.63M |
| March 31, 2023 | 161.42M |
| Date | Value |
|---|---|
| December 31, 2022 | 180.79M |
| September 30, 2022 | 189.44M |
| June 30, 2022 | 202.36M |
| December 31, 2021 | 96.70M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
96.70M
Minimum
Dec 2021
202.36M
Maximum
Jun 2022
147.53M
Average
143.63M
Median
Jun 2023
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.357M |
| Palatin Technologies Inc | 11.41M |
| iBio Inc | 34.02M |
| Theriva Biologics Inc | 48.73M |
| Oragenics Inc | 4.966M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 46.09M |
| Shareholders Equity (Quarterly) | 56.09M |